Related
Senate Pressure Grows on Novartis over Gene Therapy Data Manipulation
Rare Daily Staff Senate Finance Committee Chairman Chuck Grassley (R-Iowa) is demanding records and answers from Novartis […]
Read moreSarepta Says DMD Gene Therapy Adverse Event Report Submitted Erroneously
Rare Daily Staff Sarepta Therapeutics said that it was informed that an adverse event report regarding its […]
Read moreFDA Updates Guidance on Rare Pediatric Disease Priority Review Vouchers
Rare Daily Staff The U.S. Food and Drug Administration issued updated draft guidance on Rare Pediatric Disease […]
Read moreFDA Orphan Drug Approvals First Half 2019
Read moreFDA Orphan Drug Designations in Q2 2019
Read moreFDA Tells Acer It Won’t Approve vEDS Therapy without Additional Trial
The U.S. Food and Drug Administration rejected rare disease drug developer Acer Therapeutics’ application for marketing approval […]
Read moreCatalyst Sues FDA Over Approval of Competing LEMS Drug
Catalyst Pharmaceuticals has filed a lawsuit against the U.S. Food and Drug Administration demanding that it vacate […]
Read moreGetting Real
In the world of drug development, when things are working as they should, data drives decisions. […]
Read moreFDA Places Clinical Hold on Translate Bio’s Application to Begin Trials for mRNA Therapy
Rare Daily Staff The U.S. Food and Drug Administration has placed a clinical hold on Translate Bio’s […]
Read more